Literature DB >> 29804502

Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus.

K A Young1, M E Munroe2, J B Harley3,4, J M Guthridge2, D L Kamen5, G S Gilkensen5, M H Weisman6, D R Karp7, D J Wallace6, J A James2,8, J M Norris1.   

Abstract

Background The role of sleep in the etiology of systemic lupus erythematosus (SLE) has not been well studied. We examined whether sleep duration was associated with subsequent transitioning to SLE in individuals at risk for SLE. Methods Four hundred and thirty-six relatives of SLE patients who did not have SLE themselves at baseline were evaluated again an average of 6.3 (± 3.9) years later. Fifty-six individuals transitioned to SLE (≥ 4 cumulative American College of Rheumatology (ACR) criteria). Sleep duration, medication use and medical history were assessed by questionnaire; ACR criteria were confirmed by medical record review. Vitamin D was measured by ELISA. Generalized estimating equations, accounting for correlation within families, assessed associations between baseline sleep and the outcome of transitioning to SLE. Results Reporting sleeping less than 7 hours per night at baseline was more common in those who subsequently transitioned than those who did not transition to SLE (55% versus 32%, p = 0.0005; OR: 2.8, 95% CI 1.6-4.9). Those who transitioned to SLE were more likely to sleep less than 7 hours per night than those who did not transition to SLE adjusting for age, sex and race (OR: 2.8, 95% CI 1.6-5.1). This association remained after individual adjustment for conditions and early symptoms that could affect sleep, including prednisone use, vitamin D deficiency and number of ACR criteria (OR: 2.0, 95% CI 1.1-4.2). Conclusion Lack of sleep may be associated with transitioning to SLE, independent of early clinical manifestations of SLE that may influence sleep duration. Further evaluation of sleeping patterns and biomarkers in at-risk individuals is warranted.

Entities:  

Keywords:  SLE; depression; environmental factors; pre-clinical disease; sleep

Mesh:

Year:  2018        PMID: 29804502      PMCID: PMC6026567          DOI: 10.1177/0961203318778368

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.858


  49 in total

Review 1.  Biochemical regulation of sleep and sleep biomarkers.

Authors:  James M Clinton; Christopher J Davis; Mark R Zielinski; Kathryn A Jewett; James M Krueger
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

2.  Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation.

Authors:  Michael R Irwin; Minge Wang; Capella O Campomayor; Alicia Collado-Hidalgo; Steve Cole
Journal:  Arch Intern Med       Date:  2006-09-18

Review 3.  Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation.

Authors:  Michael R Irwin; Richard Olmstead; Judith E Carroll
Journal:  Biol Psychiatry       Date:  2015-06-01       Impact factor: 13.382

Review 4.  Sleep loss and inflammation.

Authors:  Janet M Mullington; Norah S Simpson; Hans K Meier-Ewert; Monika Haack
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-10       Impact factor: 4.690

5.  Correlates of sleep abnormalities in systemic lupus: a cross-sectional survey in an urban, academic center.

Authors:  Ernest R Vina; Stephanie L Green; Tarak Trivedi; C Kent Kwoh; Tammy O Utset
Journal:  J Clin Rheumatol       Date:  2013-01       Impact factor: 3.517

Review 6.  Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders.

Authors:  Alexandros N Vgontzas; George P Chrousos
Journal:  Endocrinol Metab Clin North Am       Date:  2002-03       Impact factor: 4.741

7.  Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.

Authors:  Kendra A Young; Melissa E Munroe; Joel M Guthridge; Diane L Kamen; Timothy B Niewold; Gary S Gilkeson; Michael H Weisman; Mariko L Ishimori; Jennifer Kelly; Patrick M Gaffney; Kathy H Sivils; Rufei Lu; Daniel J Wallace; David R Karp; John B Harley; Judith A James; Jill M Norris
Journal:  Ann Rheum Dis       Date:  2016-06-09       Impact factor: 19.103

8.  Associated factors and psychotherapy on sleep disturbances in systemic lupus erythematosus.

Authors:  N Kasitanon; U Achsavalertsak; B Maneeton; S Wangkaew; S Puntana; W Sukitawut; W Louthrenoo
Journal:  Lupus       Date:  2013-09-30       Impact factor: 2.911

9.  The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model.

Authors:  P S McKinley; S C Ouellette; G H Winkel
Journal:  Arthritis Rheum       Date:  1995-06

10.  Association of systemic lupus erythematosus and sleep disorders: a nationwide population-based cohort study.

Authors:  W S Chung; C L Lin; C H Kao
Journal:  Lupus       Date:  2015-11-18       Impact factor: 2.911

View more
  9 in total

Review 1.  Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes.

Authors:  Giulia Frazzei; Ronald F van Vollenhoven; Brigit A de Jong; Sarah E Siegelaar; Dirkjan van Schaardenburg
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 2.  Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development.

Authors:  May Y Choi; Karen H Costenbader
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

3.  Causal Relationship Between Sleep Traits and Risk of Systemic Lupus Erythematosus: A Two-Sample Mendelian Randomization Study.

Authors:  Ni Sang; Rui-Chen Gao; Meng-Yao Zhang; Zhen-Zhen Wu; Zhen-Gang Wu; Guo-Cui Wu
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 4.  Fatigue, Sleep, and Autoimmune and Related Disorders.

Authors:  Mark R Zielinski; David M Systrom; Noel R Rose
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

5.  Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention: Randomized Controlled Pilot Trial.

Authors:  Faiz Khan; Nora Granville; Raja Malkani; Yash Chathampally
Journal:  J Med Internet Res       Date:  2020-10-20       Impact factor: 5.428

Review 6.  Role of sleep deprivation in immune-related disease risk and outcomes.

Authors:  Sergio Garbarino; Paola Lanteri; Nicola Luigi Bragazzi; Nicola Magnavita; Egeria Scoditti
Journal:  Commun Biol       Date:  2021-11-18

7.  Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals.

Authors:  Melissa E Munroe; Kendra A Young; Joel M Guthridge; Diane L Kamen; Gary S Gilkeson; Michael H Weisman; Mariko L Ishimori; Daniel J Wallace; David R Karp; John B Harley; Jill M Norris; Judith A James
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 8.  Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Authors:  Isaac T W Harley; Kristen Allison; R Hal Scofield
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

Review 9.  Circadian rhythms and renal pathophysiology.

Authors:  Rajesh Mohandas; Lauren G Douma; Yogesh Scindia; Michelle L Gumz
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.